submit to the journals

Alzheimer's Disease & Dementia Journal Articles, Videos And Insights

Alzheimer's Disease & Dementia: FEATURED Articles

flipper_slider

Alzheimer's Disease & Dementia: Latest Articles

Alzheimer's Disease & Dementia: FEATURED VIDEOS

Editor's choice

Guillermo Garcia-Ribas (Spain), Richard Dodel (Germany), Evelien Lemstra (The Netherlands) and Alessandro Padovani (Italy) discuss key insights in the diagnosis and management of patients with DLB, and highlight the latest technology and benefits of an early and accurate diagnosis. The full article relating to this video can be viewed here. Questions 1. In your opinion, what are the main difficulties in relation to the diagnosis of dementia with Lewy bodies (DLB) in your country? (0:12) 2. In terms of patient management, what are the main differences between a patient with Alzheimer’s disease and a patient with DLB? (1:33) 3. What are the benefits expected for a patient, their family and caregivers, who receive an early accurate DLB diagnosis? (3:23) 4. What are the main imaging tools that help you to make an early diagnosis of DLB? (5:55) 5. From a medico-economic point of view, what are the benefits of establishing an early diagnosis of DLB? (6:52) Disclosures Guillermo Garcia-Ribas declares financial disclosures with GE Healthcare, Novartis, MSD, Grifols, Roche/Genentech, Neuronbio, Biocross, Piramal, Alter, Laboratorios Esteve, Krka, Nutricia, Fundación CIEN, Pfizer and Lilly. Richard Dodel has acted as a consultant for Adept Field Solution, AstraZeneca, Avos Consulting, Baxter, Contingo Consulting, Group H, Lilly, MedPanel, Merz, Novartis, Octapharma, Pfizer and Piramal; received research funding from Abbott, AOK Plus/infas Institut, Baxter, BMBF, Deutsche Forschungsgemeinschaft, Deutsche Gesellschaft für Neurologie, Deutsche Parkinson Vereinigung, EU Horizon 2020, Faber-Stiftung, Hector-Stiftung, Internationale Parkinson Fonds, Lundbeck, Novartis, and Rhön-Klinikum; and received honoraria from AbbVie, DZNE, Lundbeck, Med Update, Novartis, Paul-Martini-Stiftung, Studienstiftung des deutschen Volkes. Evelien Lemstra has received no personal compensation from any organisations other than the VU University Center, Amsterdam, which has contract research partnerships with GE Healthcare, Piramal Imaging, Merck, Nutricia, Probiodrug, EIP Pharma, Roche AG and Boehringer Ingelheim. Alessandro Padovani has acted as a consultant for GE Healthcare. Filmed at a GE Healthcare-sponsored educational meeting on DLB, held in London, UK on 23 March 2018.
Philip Scheltens (EAN Programme Committee; Professor of Cognitive Neurology and Director, Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands) speaks to us following his Edouard Brown-Séquard Lecture during the Presidential Symposium entitled: The evolution of Alzheimer’s disease and dementia. Questions 1. How have diagnostic criteria evolved in Alzheimer’s disease (AD)? (0:12) 2. What progress has been made in research to identify biomarkers in AD? (0:41) 3. What is your opinion on the concept of mild cognitive impairment to detect early AD? (1:16) 4. Why have so many clinical trials for AD failed? (1:50) 5. What new treatment modalities do you expect to emerge in the coming year? (2:32) Speaker disclosure: Philip Scheltens has nothing to disclose in relation to this video interview. Filmed at the 4th Congress of the European Academy of Neurology (EAN), Lisbon, Portugal, June 2018.

Alzheimer's Disease & Dementia: Latest Videos

Video List based on Category on Node Page

Latest Videos

Guillermo Garcia-Ribas (Spain), Richard Dodel (Germany), Evelien Lemstra (The Netherlands) and Alessandro Padovani (Italy) discuss key insights in the diagnosis and management of patients with DLB, and highlight the latest technology and benefits of an early and accurate diagnosis. The full...
In this two-part interview, Zuzana Walker, University College London, gives her expert opinion on the impact of early diagnosis and misdiagnosis of dementia with Lewy bodies (DLB), and current strategies for caregivers and family members. The full article relating to this video can be viewed...
Ian McKeith (UK) discusses the key highlights of the most recent dementia with Lewy bodies (DLB) meeting in London in 2018 and the importance of bringing together experts to discuss best practice for diagnosis of DLB and any obstacles that they may have come across in their healthcare...
Submit an abstract to share your discoveries at the Alzheimer‘s Association International Conference® 2019 (AAIC®), the world’s largest and most influential dementia research conference. Learn more at alz.org/AAIC.
George Perry (University of Texas at San Antonio [UTSA], San Antonio, TX), a valued member of our editorial board for US Neurology, discusses therapeutic targets in Alzheimer's disease with a particular focus on the role of oxidative stress in the underlying pathophysiology of the...
Philip Scheltens (EAN Programme Committee; Professor of Cognitive Neurology and Director, Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands) speaks to us following his Edouard Brown-Séquard Lecture during the Presidential Symposium entitled: The evolution of Alzheimer’s disease...

LATEST TWEETS

Conference Highlights